How should Bell's palsy be managed in a pregnant patient?

Management of Bell's Palsy in Pregnancy

Pregnant women with Bell's palsy should receive oral corticosteroids within 72 hours of symptom onset, as the evidence supporting steroid efficacy in non-pregnant adults applies equally to pregnancy, and the benefits of preventing permanent facial nerve damage outweigh the minimal fetal risks of a short corticosteroid course. 1, 2

Corticosteroid Therapy (First-Line Treatment)

• Prescribe prednisolone 50–60 mg once daily for 5 days, then taper over 5 days (total 10-day course), or prednisolone 25 mg twice daily for 10 days. 2

• Treatment must be initiated within 72 hours of facial weakness onset; efficacy drops markedly after this window. 2

• The American Academy of Otolaryngology–Head and Neck Surgery guidelines explicitly state that pregnant women should be treated on an individualized basis when considering combination antiviral therapy, but this caveat applies to antivirals, not to corticosteroids themselves—steroids remain the cornerstone. 1

• Only one-third of pregnant women receive corticosteroid treatment in real-world practice, representing a critical treatment gap that contributes to worse outcomes in this population. 3

Evidence Supporting Steroid Use in Pregnancy

• In non-pregnant adults, steroids achieve 83% recovery at 3 months versus 63.6% with placebo (p < 0.001) and 94.4% recovery at 9 months versus 81.6% with placebo. 2

• Pregnant and postpartum women have significantly worse facial function outcomes (mean Sunnybrook score 74 at 3 months) compared to non-pregnant controls (score 83), making early aggressive treatment even more critical. 3

• Pregnancy-associated Bell's palsy has worse long-term prognosis than in non-pregnant individuals, with higher rates of complete facial paralysis and incomplete recovery. 4, 5

• The majority of treated pregnant patients (58%) achieve complete recovery, supporting the benefit of corticosteroid therapy. 6

Timing and Epidemiology

• The third trimester is the highest-risk period, accounting for 65% of pregnancy-associated cases (n = 364/559). 6

• The incidence of pregnancy-associated Bell's palsy ranges from 60.5 to 171.6 per 100,000 person-years, substantially higher than in non-pregnant populations. 3, 7

• Most cases occur in the third trimester or immediate postpartum period (within 6 weeks of delivery). 6, 3

Antiviral Therapy

• Antivirals alone provide no benefit and should never be used as monotherapy. 2

• Adding antivirals to steroids may be considered only for severe or complete facial paralysis after discussing risks and benefits with the patient; one trial showed 96.5% recovery with combination therapy versus 89.7% with steroids alone, a modest 6.8% absolute benefit. 1, 2

• The decision to add antivirals in pregnancy requires weighing the uncertain marginal benefit against potential fetal drug exposure, but the evidence for antivirals is weak even in non-pregnant populations. 1

Mandatory Eye Protection

• Immediate eye protection is required for any patient with impaired eyelid closure to prevent corneal abrasion, exposure keratitis, ulceration, and permanent vision loss. 2

• Prescribe artificial tears every 1–2 hours while awake, lubricating ointment at bedtime, and tape or patch the eyelid closed during sleep. 2

• Instruct the patient to monitor for burning, itching, irritation, vision changes, or pain and seek urgent ophthalmologic evaluation if these occur. 2

Risk Factors Specific to Pregnancy

• Preeclampsia is the most common comorbidity associated with pregnancy-related Bell's palsy (aOR 2.02,95% CI 1.74–2.35). 6, 7

• Other risk factors include gestational diabetes (aOR 1.68), high BMI (e.g., BMI 30–34.9: aOR 1.30), multiple pregnancy (aOR 1.83), and herpes zoster (aOR 6.55). 7

• Women born in Africa (aOR 1.76), South America (aOR 1.85), or Asia (aOR 1.19) have elevated risk. 7

Diagnostic Approach

• Bell's palsy is a diagnosis of exclusion requiring rapid onset (< 72 hours) of unilateral facial weakness that includes the forehead, distinguishing it from stroke, which typically spares forehead function. 2

• Routine laboratory tests, imaging (CT/MRI), and electrodiagnostic studies are not indicated in typical presentations. 2

Red-Flag Findings Requiring MRI with Gadolinium

• Bilateral facial palsy, isolated branch paralysis sparing the forehead, additional cranial nerve deficits, recent temporal bone trauma or known tumor, or lack of recovery after 3 months. 2

Follow-Up and Referral

• Refer to a facial nerve specialist if incomplete recovery persists at 3 months post-onset. 2

• Refer immediately for new or worsening neurologic findings or new ocular symptoms (corneal irritation, decreased tear production, vision changes). 2

Critical Pitfalls to Avoid

• Missing the 72-hour treatment window—counsel all pregnant patients with acute facial weakness to seek immediate care. 2, 4

• Withholding corticosteroids due to pregnancy concerns—the short-term fetal risks of a 10-day prednisolone course are minimal compared to the risk of permanent maternal facial nerve damage and its impact on quality of life. 4, 5

• Prescribing antivirals alone—this is ineffective and wastes the critical treatment window. 2

• Neglecting eye protection—corneal injury can occur rapidly and cause permanent vision loss. 2

• Under-treating based on the assumption of spontaneous recovery—pregnant women have worse outcomes than non-pregnant individuals and require aggressive early therapy. 3, 4

Interventions Lacking Evidence

• Surgical facial nerve decompression, acupuncture, and routine physical therapy are not recommended due to insufficient evidence. 2

• Physical therapy may be considered for patients with severe paralysis or incomplete recovery at 3 months, but high-quality data are lacking. 2